Interest comment in the Half Yearly - "To date, we have treated 23 of the 24 patients that our increased quota will allow for. We are currently in discussions with the FDA to increase the number of patients allotted under this program, based on the demonstrated need for our technology". Very positive, given it is the physician's call to make when there isn't an alternative.
Ann: Half Year Report and Accounts, page-2
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.17 |
Change
0.180(6.02%) |
Mkt cap ! $223.2M | |||
| Open | High | Low | Value | Volume |
| $3.17 | $3.18 | $3.12 | $1.124M | 356.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 410 | $3.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.17 | 2434 | 1 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| AVH (ASX) Chart |